<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Card Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Ann Card Anaesth</journal-id><journal-id journal-id-type="publisher-id">ACA</journal-id><journal-title-group><journal-title>Annals of Cardiac Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0971-9784</issn><issn pub-type="epub">0974-5181</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26139745</article-id><article-id pub-id-type="pmc">4881722</article-id><article-id pub-id-type="publisher-id">ACA-18-385</article-id><article-id pub-id-type="doi">10.4103/0971-9784.159810</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article - Janak Mehta Award</subject></subj-group></article-categories><title-group><article-title>Nonanalgesic benefits of combined thoracic epidural analgesia with general anesthesia in high risk elderly off pump coronary artery bypass patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zawar</surname><given-names>Bhanu Prakash</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Yatin</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Juneja</surname><given-names>Rajiv</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Arora</surname><given-names>Dheeraj</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Raizada</surname><given-names>Arun</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Trehan</surname><given-names>Naresh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Institute of Critical Care Anesthesiology, Medanta - The Medicity, Gurgaon, Haryana, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Yatin Mehta, Institute of Critical Care Anesthesiology, Medanta - The Medicity, Sector 38, Gurgaon, Haryana, India. E-mail: <email xlink:href="yatinmehta@hotmail.com">yatinmehta@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2015</year></pub-date><volume>18</volume><issue>3</issue><fpage>385</fpage><lpage>391</lpage><history><date date-type="received"><day>10</day><month>1</month><year>2015</year></date><date date-type="accepted"><day>19</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2015 Annals of Cardiac Anaesthesia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>Epidural anesthesia is a central neuraxial block technique with many applications. It is a versatile anesthetic technique, with applications in surgery, obstetrics and pain control. Its versatility means it can be used as an anesthetic, as an analgesic adjuvant to general anesthesia, and for postoperative analgesia. Off pump coronary artery bypass (OPCAB) surgery triggers a systemic stress response as seen in coronary artery bypass grafting (CABG). Thoracic epidural anesthesia (TEA), combined with general anesthesia (GA) attenuates the stress response to CABG. There is Reduction in levels of Plasma epinephrine, Cortisol and catecholamine surge, tumor necrosis factor-Alpha(TNF &#x003ac;), interleukin-6 and leucocyte count.</p></sec><sec id="st2"><title>Design:</title><p>A prospective randomised non blind study.</p></sec><sec id="st3"><title>Setting:</title><p>A clinical study in a multi specialty hospital.</p></sec><sec id="st4"><title>Participants:</title><p>Eighty six patients.</p></sec><sec id="st5"><title>Material and Methods/intervention:</title><p>The study was approved by hospital research ethics committee and written informed consent was obtained from all patients. Patients were randomised to receive either GA plus epidural (study group) or GA only (control group). Inclusion Criteria (for participants) were -Age &#x02265; 70 years, Patient posted for OPCAB surgery, and patient with comorbidities (diabetes mellitus, chronic obstructive pulmonary disease, cerebrovascular disease, peripheral vascular disease, renal dysfunction). Serum concentration of Interlukin: &#x02013; 6, TNF &#x003ac;, cortisol, Troponin &#x02013; I, CK-MB, and HsCRP (highly sensitive C reactive protein), was compared for both the group and venous blood samples were collected and compared just after induction, at day 2, and day 5 postoperatively. Time to mobilization, extubation, total intensive care unit stay and hospital stay were noted and compared. Independent t test was used for statistical analysis.</p></sec><sec id="st6"><title>Primary Outcomes:</title><p>Postoperative complications, total intensive care unit stay and hospital stay.</p></sec><sec id="st7"><title>Secondary Outcome:</title><p>Stress response.</p></sec><sec id="st8"><title>Result:</title><p>Study group showed decreased Interlukin &#x02013; 6 at day 2, TNF &#x003ac; at day 2 and 5, troponin I at day 5, and decreased total hospital stay (p &#x0003c; 0.05).</p></sec><sec id="st9"><title>Conclusion:</title><p>Thoracic epidural anesthesia decreases stress and inflammatory response to surgery and decreases hospital stay. However a large multicentre study may be needed to confirm it.</p></sec></abstract><kwd-group><kwd>Coronary artery bypass grafting</kwd><kwd>inflammatory markers</kwd><kwd>off pump coronary artery bypass</kwd><kwd>thoracic epidural anesthesia</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>As a result of increasing life expectancy, the number of coronary artery bypass grafting (CABG) has increased in the elderly. Advanced age is associated with the physiologic process of aging and decreased functional reserve of organs. These patients are often frail and have comorbid conditions such as diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), cerebrovascular disease, peripheral vascular disease (PVD), and renal dysfunction.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>] These characteristics translate to increased postoperative complications and resource utilization following CABG. Advanced age remains an independent predictor of mortality and morbidity in CABG.[<xref rid="ref3" ref-type="bibr">3</xref>]</p><p>Older patients have delayed extubation prolonged Intensive Care Unit (ICU) and hospital length of stay (HLOS), blood transfusion, respiratory complications, low output syndrome, stroke, hospital mortality, renal insufficiency, perioperative myocardial infarction (PMI), and arrhythmias such as atrial fibrillation and ventricular arrhythmias.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Despite on-going advances in endovascular revascularization, CABG is expected to remain an indispensable method of coronary revascularization.[<xref rid="ref7" ref-type="bibr">7</xref>] Furthermore, patient selection for surgery is not always straightforward as the majority of these patients are operated for symptoms rather than for longevity.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>In an effort to reduce morbidity and mortality in elderly patients for CABG, reappraisal of off-pump CAB (OPCAB) has shown promise in reducing the above mentioned postoperative complications in the elderly, compared with conventional CABG (CCABG) on cardiopulmonary bypass (CPB).[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref3" ref-type="bibr">3</xref>] Several studies have demonstrated that CABG in patients more than 70 years of age can be performed successfully with good late outcomes through morbidity and morbidity remains higher as compared to younger patients.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] Many studies have recommended that these patients should not be turned down for coronary revascularization because of advanced age alone.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] Various benefits of thoracic epidural analgesia (TEA) in high risk cardiac surgical patient such as earlier tracheal extubation, decreased pulmonary, cardiovascular, or renal complications are described.[<xref rid="ref13" ref-type="bibr">13</xref>] The surgical treatment of this group of patients nonetheless poses general anesthesia (GA) related and ethical challenges. Nonanalgesic benefits of GA and TEA have not been well studied particularly in the high risk population. We undertook a study to analyze the nonanalgesic benefits of combined GA with TEA in elderly high risk subgroup of patients.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Study design</title><p>This was a single center, prospective, randomized, controlled trail. Eligible patients were elderly (age &#x0003e; 70) undergoing primary OPCAB surgery without the use of CPB and cardioplegic arrest. Patient with infection over the spine, coagulation disorders, emergency cases, unstable angina, left main stem disease, patients with dysrhythmias, undergoing combined procedures, patient on intra-aortic balloon counter pulsation (IABP), and patient on antiplatelet agent, low molecular weight heparin or heparin infusion were excluded from the study.</p><p>Preoperative demographics age, sex, and clinical profile with regards to: Ejection fraction (EF), comorbid conditions (DM, COPD, cerebrovascular disease, PVD, renal dysfunction), and hypertension were noted. Time to extubation, time to mobilization, ICU, and HLOS were recorded. Postoperative complications such as reintubation, postoperative IABP requirement, blood and blood product transfusion rates, PMI, occurrence of stroke, atrial and ventricular arrhythmias, new onset renal dysfunction, gastrointestinal complications, and respiratory complications were noted.</p><p>New onset renal dysfunction was defined as rise of serum creatinine to more than 2 mg/dl in patients with normal preoperative serum creatinine values or rise of more than 2 mg/dl from preoperative values if abnormal. PMI was defined as those developing electrocardiogram (ECG) changes-new Q waves on postoperative ECG &#x02265;0.03 s in duration in two or more adjacent leads lasting till discharge, rise in creatine phosphokinase-MB (CPK-MB) and troponin I, new regional wall motion abnormalities. Respiratory complications like ventilator associated pneumonia or atelectasis requiring noninvasive ventilation in the postoperative period were noted. Atrial fibrillation was documented if it lasted more than 24 h. Stroke was documented if diagnosed on computed tomography scan or magnetic resonance imaging (MRI). Blood sampling: CPK-MB, troponin I, interleukin-6 (IL-6), tumor necrosis factor-&#x003b1; (TNF-&#x003b1;), highly sensitive C-reactive protein (HsCRP), serum cortisol were measured. Venous blood samples for these were collected at the following time interval: Postanesthesia induction, day 2 and day 5.</p><p>HsCRP was measured using latex enhanced turbidimetric immunoassay. Troponin T (Tn-T) was measured using the immunometric method. Creatine kinase MB (CK-MB) was measured using creatine phosphate/GPO/POD &#x02013; immunoassay method. Cortisol was measured using competitive immunoassay method. IL-6 and TNF-&#x003b1; were measured using ELISA. Serum concentration of IL-6, TNF-&#x003b1;, cortisol, CK-MB, Tn-T, and HsCRP, were compared between both the groups.</p></sec><sec id="sec2-2"><title>Study settings</title><p>The study was conducted at our tertiary care hospital. After approved by the Institutional Review Board of the Hospital, written informed consent was obtained from all patients.</p></sec><sec id="sec2-3"><title>Interventions</title><p>It was a nonblinded study. Patients were randomized to receive either GA plus TEA (study group) or GA (control group) by computer generated numbers in sealed envelopes.</p></sec><sec id="sec2-4"><title>Anesthetic technique</title><p>In both groups, the patients were premedicated with lorazepam 2 mg and pantoprazole 40 mg per orally a night before and on the morning of surgery. Anesthesia was induced with thiopentone sodium 2&#x02013;4 mg/kg combined with fentanyl sulfate (3&#x02013;5 &#x003bc;/kg) and midazolam 0.03&#x02013;0.04 mg/kg intravenously (IV). Neuromuscular blockade was achieved with 0.08&#x02013;0.12 mg/kg pancuronium or vecuronium bromide and following tracheal intubation, the lungs were ventilated with oxygen and air to normocapnia. Anesthesia was maintained with isoflurane and intermittent doses of muscle relaxant, fentanyl sulfate, and midazolam. In addition, patients in the study group had a thoracic epidural catheter sited immediately before induction between C7-T1 and T1-T2 intervertebral space. The epidural needle was inserted using the hanging drop technique in the sitting position, and the epidural catheter was inserted 4&#x02013;5 cm beyond the needle tip. The neuraxial block was established from T1 to T10 with an initial bolus of 6&#x02013;14 ml ropivacaine 0.75%, followed by infusion of 5&#x02013;15 ml/h ropivacaine 0.2%. The effect was confirmed by a sensory loss to cold pack and needle prick. If a &#x0201c;bloody tap&#x0201d; was to occur, the operation was postponed for 24 h and excluded from the study. Surgery commenced only if the neurologic examination was normal the next morning. Any focal neurologic abnormality was to be followed by urgent MRI scan to exclude epidural hematoma.</p></sec><sec id="sec2-5"><title>Surgical technique</title><p>Heparin (200 units/kg) was administered after harvesting the left internal mammary artery to achieve an activated clotting time of 300&#x02013;350 s. On completion of all anastomoses, protamine sulfate was administered to reverse the effect of heparin and return the activated clotting time to &#x0003c;150 s.</p></sec><sec id="sec2-6"><title>Postoperative care</title><p>In the study group, the epidural infusion was continued for 72 h after surgery. Visual Analog Score for the intensity of pain was assessed on a scale of 1&#x02013;10 with the maximum intensity of pain being graded as 10. The rate of infusion was titrated by the attending intensivist according to clinical need/pain score. &#x0201c;Top-up&#x0201d; bolus doses up to a maximum of 4 ml ropivacaine, 0.2%, were administered when the patient complained of pain. If more than three increases to the infusion rate or more than three epidural top-up doses were required in any hour, analgesia was considered inadequate, and a rescue analgesic tramadol hydrochloride 100 mg IV was administered. All patients in the control group received tramadol hydrochloride 100 mg IV 8 hourly. All other aspects of postoperative patient management were according to unit protocol.</p></sec><sec id="sec2-7"><title>Statistical methods</title><p>All the values are expressed as in terms of means and standard deviation. Qualitative/categorical data are expressed in terms of absolute number and percentages. Comparison between study and control groups was performed using independent Student's <italic>t</italic>-test. The Chi-square test was used for categorical data. Diagrams and charts are given wherever necessary to substantiate the important findings. All statistical tests were two-tailed, and a <italic>P</italic> &#x0003c; 0.05 was considered statistically significant. Statistical analysis was performed in SPSS version 18.0 (IBM, SPSS statistics).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><sec id="sec2-8"><title>Patient recruitment</title><p>Patient recruitment took place between December 2011 and November 2014. Eighty-six patients enrolled in the study were randomly assigned to study and control groups, with 40 assigned to study (five patients excluded from the study group due to protocol violations) and 46 to control group.</p></sec><sec id="sec2-9"><title>Protocol violations</title><p>There were five protocol violations in patients allocated to the study group, two epidural catheters were accidentally dislodged during shifting of the patient, one patient developed severe hypotension requiring a bolus of epinephrine during catheter placement without any clinical consequences. One OPCAB was converted to CABG due to hemodynamic instability during surgery. One patient withdrew consent from the trial. None of the patients had &#x0201c;bloody tap&#x0201d; during epidural catheter placement.</p></sec><sec id="sec2-10"><title>Baseline characteristics and operative details</title><p>Patient demographics are presented in <xref ref-type="table" rid="T1">Table 1</xref>. Patients mean age was 74.9 years in the control group (standard deviation [ SD] &#x000b1; 4.162 years), and 74.2 years in the study group (SD &#x000b1; 5.138). About 89.1% were males in control group and 88.6% in study group. Patient characteristics such as EF, the prevalence of COPD, DM, PVD, and hypertension were similar in both groups [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Comparison of patient demographics and various postoperative parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study parameters</th><th align="center" rowspan="1" colspan="1">Control group (<italic>n</italic>=46)</th><th align="center" rowspan="1" colspan="1">Study group (<italic>n</italic>=35)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Demographic profile</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Male, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">41 (89.1)</td><td align="center" rowspan="1" colspan="1">31 (88.6)</td><td align="center" rowspan="1" colspan="1">0.937</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Age (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">74.9&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">74.2&#x000b1;5.1</td><td align="center" rowspan="1" colspan="1">0.492</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;BMI (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">25.2&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">26.1&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">0.386</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;EF (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">48.2&#x000b1;9.7</td><td align="center" rowspan="1" colspan="1">48.3&#x000b1;7.8</td><td align="center" rowspan="1" colspan="1">0.989</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;DM, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">23 (50.0)</td><td align="center" rowspan="1" colspan="1">20 (57.1)</td><td align="center" rowspan="1" colspan="1">0.523</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;COPD, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">5 (10.9)</td><td align="center" rowspan="1" colspan="1">7 (20.0)</td><td align="center" rowspan="1" colspan="1">0.252</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Renal dysfunction, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">5 (10.9)</td><td align="center" rowspan="1" colspan="1">1 (2.9)</td><td align="center" rowspan="1" colspan="1">0.173</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hypertension, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">25 (56.8)</td><td align="center" rowspan="1" colspan="1">17 (48.6)</td><td align="center" rowspan="1" colspan="1">0.466</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PVD, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative parameters</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Time to extubation (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">15.5&#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">14.2&#x000b1;8.2</td><td align="center" rowspan="1" colspan="1">0.353</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Time to mobilization (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">49.4&#x000b1;11.5</td><td align="center" rowspan="1" colspan="1">14.2&#x000b1;8.2</td><td align="center" rowspan="1" colspan="1">0.977</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;ICU stay (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">69.5&#x000b1;20.5</td><td align="center" rowspan="1" colspan="1">63.9&#x000b1;21.8</td><td align="center" rowspan="1" colspan="1">0.240</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hospital stay (mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">155.0&#x000b1;11.7</td><td align="center" rowspan="1" colspan="1">144.6&#x000b1;31.0</td><td align="center" rowspan="1" colspan="1">0.042*</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Blood transfusion, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">23 (50.0)</td><td align="center" rowspan="1" colspan="1">12 (34.3)</td><td align="center" rowspan="1" colspan="1">0.157</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Atrial and ventricular arrhythmias, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">1 (2.2)</td><td align="center" rowspan="1" colspan="1">3 (8.6)</td><td align="center" rowspan="1" colspan="1">0.188</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;New onset renal dysfunction, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">2 (4.3)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">0.212</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Gastrointestinal complications, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">1 (2.2)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">0.380</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Respiratory complications, n (%)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">1 (2.9)</td><td align="center" rowspan="1" colspan="1">0.249</td></tr></tbody></table><table-wrap-foot><fn><p>*<italic>P</italic>&#x0003c;0.05, statistically significant. Demographic profiles of the control group and study group were comparable. In postoperative parameters, only hospital stay is statistically significant. EF: Ejection fraction, ICU: Intensive Care Unit, BMI: Body mass index, DM: Diabetes mellitus, COPD: Chronic obstructive pulmonary disease, PVD: Peripheral vascular disease, SD: Standard deviation</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-11"><title>Primary outcome</title><p>The median time from surgery to discharge from the hospital was shorter by 10.33 h. In the study group, as compared to the control group (155 h in control and 144.6 in study group <italic>P</italic> = 0.042) [<xref ref-type="table" rid="T1">Table 1</xref>]. Time to extubation, time to mobilization, and ICU stay were comparable for both the groups (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="table" rid="T1">Table 1</xref>].</p></sec><sec id="sec2-12"><title>Secondary outcomes</title><p>The baseline values of biochemical parameters such as IL-6, TNF-&#x003b1;, troponin I, HsCRP, CPK-MB were comparable between groups at postinduction (<italic>P</italic> &#x0003e; 0.05) [Figures <xref ref-type="fig" rid="F1">1</xref>&#x02013;<xref ref-type="fig" rid="F4">4</xref>]. IL-6 was significantly lower in the study group at day 2 (43.15 pg/ml in control group vs. 35.4 pg/ml in study group) (<italic>P</italic> &#x0003c; 0.044) [<xref ref-type="fig" rid="F4">Figure 4</xref>]. TNF-&#x003b1; was significantly lower in the study group at day 2 and 5 (25.51 pg/ml in control group vs. 18.28 pg/ml in the study group at day 2 and 23.99 pg/ml in control group vs. 11.04 pg/ml in the study group at day 5) (<italic>P</italic> &#x0003c; 0.044 and 0.031), respectively [<xref ref-type="fig" rid="F4">Figure 4</xref>]. Furthermore, troponin I was significantly lower in study group at day 5 (<italic>P</italic> &#x0003c; 0.049) (0.64 &#x003bc;g/L in control group vs. 0.12 &#x003bc;g/L in the study group at day 5) [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Values of highly sensitive C-reactive protein at different time points</p></caption><graphic xlink:href="ACA-18-385-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Values of cortisol at different time points</p></caption><graphic xlink:href="ACA-18-385-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Values of troponin I at different time points. *<italic>P</italic> &#x0003c; 0.05, statistically significant</p></caption><graphic xlink:href="ACA-18-385-g003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Values of interleukin-6 and tumor necrosis factor-&#x003b1; at different time points. The values of interleukin-6 are significant at day 1. Values of and tumor necrosis factor-&#x003b1; is significant at day 1 and 2. *<italic>P</italic> &#x0003c; 0.05, statistically significant</p></caption><graphic xlink:href="ACA-18-385-g004"/></fig><p>The patients in the study and control groups had no significant difference in postoperative complication such as atrial and ventricular arrhythmias, new onset renal dysfunction, gastrointestinal, and respiratory complications [<xref ref-type="table" rid="T1">Table 1</xref>]. None of the patients in either group had a postoperative complication such as reintubation, postoperative IABP requirement, PMI, occurrence of stroke.</p></sec></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Old age remains an independent predictor of mortality and morbidity in CABG surgery.[<xref rid="ref3" ref-type="bibr">3</xref>] Our study has clearly demonstrated that administration of perioperative TEA along with GA reduces the mean length of postoperative hospital stay by 10.33 h. In high risk elderly patient undergoing OPCAB surgery. A study on 300 patients found an average reduction of 1-day of hospital stay by adding TEA to GA with &#x0201c;conventional&#x0201d; postoperative analgesia in adult patients undergoing OPCAB surgery.[<xref rid="ref14" ref-type="bibr">14</xref>]</p><p>The perioperative use of epidural analgesia has profound inhibitory effects on the body's response to surgery, improving a variety of postoperative morbidity parameters, and improves surgical outcome.[<xref rid="ref15" ref-type="bibr">15</xref>] A meta-analysis on &#x0201c;role of epidural analgesia in surgical practice&#x0201d;[<xref rid="ref16" ref-type="bibr">16</xref>] observed improvement in the surgical outcome through beneficial effects on perioperative pulmonary function, blunting surgical stress response and improved analgesia. A meta-analysis of 15 trials enrolling 1178 patients who were randomized to either GA or GA combined with TEA in patients undergoing CABG on CPB demonstrate that TEA + GA patients had a reduced incidence of dysrhythmias, pain, pulmonary complications, and ventilation times without any effect on the incidence of PMI or mortality.[<xref rid="ref17" ref-type="bibr">17</xref>] Another study showed better analgesia, associated with physiotherapy cooperation, earlier extubation, and less psychological disorders.[<xref rid="ref18" ref-type="bibr">18</xref>] We have also found TEA to be beneficial technique in patients with COPD and obesity (body mass index of more than 30 kg/m<sup>2</sup>) undergoing OPCAB surgery with better analgesia and pulmonary function test postoperatively.[<xref rid="ref19" ref-type="bibr">19</xref>] A study on 60 patients undergoing CABG on the pump with TEA versus TEA + GA observed comparable ventilator time, ICU stay, pain, and cardiopulmonary complications in both groups of patients.[<xref rid="ref20" ref-type="bibr">20</xref>] OPCAB also triggers a systemic stress response as seen in CCABG.[<xref rid="ref21" ref-type="bibr">21</xref>] TEA combined with GA attenuates the stress response to CPB and CABG. This has been seen in a reduction in levels of plasma epinephrine,[<xref rid="ref22" ref-type="bibr">22</xref>] cortisol and catecholamine surge,[<xref rid="ref23" ref-type="bibr">23</xref>] TNF-&#x003b1;, leukocyte count, and procalcitonin.[<xref rid="ref24" ref-type="bibr">24</xref>] In our study, we found significantly decreased TNF-&#x003b1; on day 2 and 5 and IL-6 on day 2 in the study group. Cystic fibrosis control group. To our knowledge, this is the first report of nonanalgesic benefits of TEA in high risk patients in the age group 70 years and above undergoing OPCAB surgery.</p><p>Epidural analgesia has also been seen to reduce the hypercoagualable response to surgery,[<xref rid="ref25" ref-type="bibr">25</xref>] improve myocardial blood flow,[<xref rid="ref26" ref-type="bibr">26</xref>] and reduce postoperative MI.[<xref rid="ref27" ref-type="bibr">27</xref>] The main argument against the use of TEA for CCABG surgery is the fear of an increased risk of epidural hematoma caused by the need to administer a large dose of heparin immediately before CPB. This perceived increased risk cannot be quantified, but the incidence of epidural hematoma after catheter insertion without heparinization is approximately 1 in 10,000.[<xref rid="ref28" ref-type="bibr">28</xref>] Such a risk must be balanced by important clinical advantages if the technique is to be justified. In OPCAB surgery, the need for heparinization is reduced to half the dose as that used for CCABG, making the use of epidural anesthesia a more attractive approach. There was one conversion to CPB in the study group, without any adverse effect. We had no such complication in this study.</p><p>We perform TEA regularly at our center with cumulative experience of more than 1000 without any case of epidural hematoma, but we strictly follow American Society of Regional Anesthesia and European Society of Regional Anesthesia guidelines for safety.[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>]</p><p>We did not find any difference in postoperative complications such as reintubation, postoperative IABP requirement, blood and blood product transfusion rates, perioperative MI, occurrence of stroke, atrial and ventricular arrhythmias, new onset renal dysfunction, gastrointestinal, and respiratory complications. It may be because these complications have a low incidence in OPCAB, and the numbers were not significant.</p><sec id="sec2-13"><title>Limitations</title><p>The main limitation of the study was that it was not blinded. The study was slow in recruiting because large numbers of patients were on intravenous heparin or antiplatelet agents. This may represent a significant limitation to the application of epidural anesthesia. The study was applicable only for patients who were aged above 70 years and undergoing OPCAB surgery.</p></sec></sec><sec sec-type="conclusions" id="sec1-5"><title>CONCLUSIONS</title><p>We have demonstrated that the addition of TEA to conventional GA accounts for a significant reduction in the stress and inflammatory response to surgery and decreases total hospital stay in high risk elderly patients undergoing OPCAB surgery. However, a large multi-centric study may be needed to confirm it.</p><sec id="sec2-14"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-15"><title>Conflict of interest</title><p>There are no conflict of interest.</p></sec></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>AP</given-names></name><name><surname>Arifi</surname><given-names>AA</given-names></name><name><surname>Wan</surname><given-names>S</given-names></name></person-group><article-title>Coronary artery bypass grafting in the elderly: The challenge and the opportunity</article-title><source>Chest</source><year>2000</year><volume>117</volume><fpage>1220</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">10807800</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascione</surname><given-names>R</given-names></name><name><surname>Rees</surname><given-names>K</given-names></name><name><surname>Santo</surname><given-names>K</given-names></name><name><surname>Chamberlain</surname><given-names>MH</given-names></name><name><surname>Marchetto</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>F</given-names></name><etal/></person-group><article-title>Coronary artery bypass grafting in patients over 70 years old: The influence of age and surgical technique on early and mid-term clinical outcomes</article-title><source>Eur J Cardiothorac Surg</source><year>2002</year><volume>22</volume><fpage>124</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12103385</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>WD</given-names></name><name><surname>Desai</surname><given-names>ND</given-names></name><name><surname>Del Rizzo</surname><given-names>DF</given-names></name><name><surname>Novick</surname><given-names>RJ</given-names></name><name><surname>McKenzie</surname><given-names>FN</given-names></name><name><surname>Menkis</surname><given-names>AH</given-names></name></person-group><article-title>Off-pump surgery decreases postoperative complications and resource utilization in the elderly</article-title><source>Ann Thorac Surg</source><year>1999</year><volume>68</volume><fpage>1490</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">10543551</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demaria</surname><given-names>RG</given-names></name><name><surname>Carrier</surname><given-names>M</given-names></name><name><surname>Fortier</surname><given-names>S</given-names></name><name><surname>Martineau</surname><given-names>R</given-names></name><name><surname>Fortier</surname><given-names>A</given-names></name><name><surname>Cartier</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reduced mortality and strokes with off-pump coronary artery bypass grafting surgery in octogenarians</article-title><source>Circulation</source><year>2002</year><volume>106</volume><issue>12 Suppl 1</issue><fpage>I5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">12354700</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>N</given-names></name><name><surname>Urita</surname><given-names>R</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Kitano</surname><given-names>I</given-names></name><name><surname>Murakami</surname><given-names>T</given-names></name></person-group><article-title>Surgical results of coronary artery bypass grafting in patients older than 75 years</article-title><source>Kyobu Geka</source><year>1997</year><volume>50</volume><fpage>656</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9251488</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christenson</surname><given-names>JT</given-names></name><name><surname>Schmuziger</surname><given-names>M</given-names></name><name><surname>Maurice</surname><given-names>J</given-names></name><name><surname>Simonet</surname><given-names>F</given-names></name><name><surname>Velebit</surname><given-names>V</given-names></name></person-group><article-title>How safe is coronary bypass surgery in the elderly patient?. Analysis of 111 patients aged 75 years or more and 2939 patients younger than 75 years undergoing coronary artery bypass grafting in a private hospital</article-title><source>Coron Artery Dis</source><year>1994</year><volume>5</volume><fpage>169</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">8180747</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamoun</surname><given-names>NF</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Leventhal</surname><given-names>M</given-names></name><name><surname>Bashour</surname><given-names>M</given-names></name></person-group><article-title>A Propensity Matched Comparison of Patients 85 Years and Older with Those 55 to 65 Years on Outcome Following CABG Surgery (Abstract)</article-title><source>Anesthesiology</source><year>2005</year><volume>103</volume><fpage>A1465</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>WS</given-names></name></person-group><article-title>Coronary operations in octogenarians: Can we select the patients?</article-title><source>Ann Thorac Surg</source><year>1995</year><volume>60</volume><fpage>875</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7574988</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Nakatani</surname><given-names>H</given-names></name><name><surname>Gomi</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Sugimoto</surname><given-names>K</given-names></name></person-group><article-title>Hospital and mid-term outcomes in elderly patients under-going off-pump coronary artery bypass grafting &#x02013; Comparison with younger patients</article-title><source>Circ J</source><year>2004</year><volume>68</volume><fpage>1184</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15564704</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deuse</surname><given-names>T</given-names></name><name><surname>Detter</surname><given-names>C</given-names></name><name><surname>Samuel</surname><given-names>V</given-names></name><name><surname>Boehm</surname><given-names>DH</given-names></name><name><surname>Reichenspurner</surname><given-names>H</given-names></name><name><surname>Reichart</surname><given-names>B</given-names></name></person-group><article-title>Early and midterm results after coronary artery bypass grafting with and without cardiopulmonary bypass: Which patient population benefits the most?</article-title><source>Heart Surg Forum</source><year>2003</year><volume>6</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">12716586</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapira</surname><given-names>I</given-names></name><name><surname>Isakov</surname><given-names>A</given-names></name><name><surname>Heller</surname><given-names>I</given-names></name><name><surname>Topilsky</surname><given-names>M</given-names></name></person-group><article-title>Elderly patients as candidates for bypass?</article-title><source>Chest</source><year>2001</year><volume>119</volume><fpage>318</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11157635</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>H</given-names></name><name><surname>Amano</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Nagano</surname><given-names>N</given-names></name><name><surname>Kohmoto</surname><given-names>T</given-names></name></person-group><article-title>Coronary artery bypass grafting in the elderly</article-title><source>Chest</source><year>2000</year><volume>117</volume><fpage>1262</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10807809</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>Y</given-names></name><name><surname>Arora</surname><given-names>D</given-names></name><name><surname>Vats</surname><given-names>M</given-names></name></person-group><article-title>Epidural analgesia in high risk cardiac surgical patients</article-title><source>HSR Proc Intensive Care Cardiovasc Anesth</source><year>2012</year><volume>4</volume><fpage>11</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">23440670</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caputo</surname><given-names>M</given-names></name><name><surname>Alwair</surname><given-names>H</given-names></name><name><surname>Rogers</surname><given-names>CA</given-names></name><name><surname>Pike</surname><given-names>K</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Monk</surname><given-names>C</given-names></name><etal/></person-group><article-title>Thoracic epidural anesthesia improves early outcomes in patients undergoing off-pump coronary artery bypass surgery: A prospective, randomized, controlled trial</article-title><source>Anesthesiology</source><year>2011</year><volume>114</volume><fpage>380</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">21245735</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekatodramis</surname><given-names>G</given-names></name></person-group><article-title>Regional anesthesia and analgesia: Their role in postoperative outcome</article-title><source>Curr Top Med Chem</source><year>2001</year><volume>1</volume><fpage>183</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11895134</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraca</surname><given-names>RJ</given-names></name><name><surname>Sheldon</surname><given-names>DG</given-names></name><name><surname>Thirlby</surname><given-names>RC</given-names></name></person-group><article-title>The role of epidural anesthesia and analgesia in surgical practice</article-title><source>Ann Surg</source><year>2003</year><volume>238</volume><fpage>663</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">14578727</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SS</given-names></name><name><surname>Block</surname><given-names>BM</given-names></name><name><surname>Wu</surname><given-names>CL</given-names></name></person-group><article-title>Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: A meta-analysis</article-title><source>Anesthesiology</source><year>2004</year><volume>101</volume><fpage>153</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">15220785</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royse</surname><given-names>C</given-names></name><name><surname>Royse</surname><given-names>A</given-names></name><name><surname>Soeding</surname><given-names>P</given-names></name><name><surname>Blake</surname><given-names>D</given-names></name><name><surname>Pang</surname><given-names>J</given-names></name></person-group><article-title>Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>75</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">12537199</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Mehta</surname><given-names>Y</given-names></name><name><surname>Sawhney</surname><given-names>R</given-names></name><name><surname>Vats</surname><given-names>M</given-names></name><name><surname>Trehan</surname><given-names>N</given-names></name></person-group><article-title>Thoracic epidural analgesia in obese patients with body mass index of more than 30 kg/m2 for off pump coronary artery bypass surgery</article-title><source>Ann Card Anaesth</source><year>2010</year><volume>13</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">20075532</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillinger</surname><given-names>MP</given-names></name><name><surname>Yeager</surname><given-names>MP</given-names></name><name><surname>Dodds</surname><given-names>TM</given-names></name><name><surname>Fillinger</surname><given-names>MF</given-names></name><name><surname>Whalen</surname><given-names>PK</given-names></name><name><surname>Glass</surname><given-names>DD</given-names></name></person-group><article-title>Epidural anesthesia and analgesia: Effects on recovery from cardiac surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2002</year><volume>16</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">11854872</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velissaris</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>AT</given-names></name><name><surname>Murray</surname><given-names>M</given-names></name><name><surname>Mehta</surname><given-names>RL</given-names></name><name><surname>Wood</surname><given-names>PJ</given-names></name><name><surname>Hett</surname><given-names>DA</given-names></name><etal/></person-group><article-title>A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization</article-title><source>Ann Thorac Surg</source><year>2004</year><volume>78</volume><fpage>506</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15276508</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loick</surname><given-names>HM</given-names></name><name><surname>Schmidt</surname><given-names>C</given-names></name><name><surname>Van Aken</surname><given-names>H</given-names></name><name><surname>Junker</surname><given-names>R</given-names></name><name><surname>Erren</surname><given-names>M</given-names></name><name><surname>Berendes</surname><given-names>E</given-names></name><etal/></person-group><article-title>High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting</article-title><source>Anesth Analg</source><year>1999</year><volume>88</volume><fpage>701</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10195508</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganapathy</surname><given-names>S</given-names></name><name><surname>Murkin</surname><given-names>JM</given-names></name><name><surname>Dobkowski</surname><given-names>W</given-names></name><name><surname>Boyd</surname><given-names>D</given-names></name></person-group><article-title>Stress and inflammatory response after beating heart surgery versus conventional bypass surgery: The role of thoracic epidural anesthesia</article-title><source>Heart Surg Forum</source><year>2001</year><volume>4</volume><fpage>323</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11827861</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>F</given-names></name><name><surname>Grundmann</surname><given-names>U</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Buchinger</surname><given-names>H</given-names></name><name><surname>Solt&#x000e9;sz</surname><given-names>S</given-names></name><name><surname>Graeter</surname><given-names>T</given-names></name><etal/></person-group><article-title>Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia</article-title><source>Acta Anaesthesiol Scand</source><year>2002</year><volume>46</volume><fpage>1227</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">12421195</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuman</surname><given-names>KJ</given-names></name><name><surname>McCarthy</surname><given-names>RJ</given-names></name><name><surname>March</surname><given-names>RJ</given-names></name><name><surname>DeLaria</surname><given-names>GA</given-names></name><name><surname>Patel</surname><given-names>RV</given-names></name><name><surname>Ivankovich</surname><given-names>AD</given-names></name></person-group><article-title>Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery</article-title><source>Anesth Analg</source><year>1991</year><volume>73</volume><fpage>696</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">1952169</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyg&#x000e5;rd</surname><given-names>E</given-names></name><name><surname>Kofoed</surname><given-names>KF</given-names></name><name><surname>Freiberg</surname><given-names>J</given-names></name><name><surname>Holm</surname><given-names>S</given-names></name><name><surname>Aldershvile</surname><given-names>J</given-names></name><name><surname>Eliasen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease</article-title><source>Circulation</source><year>2005</year><volume>111</volume><fpage>2165</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15851604</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beattie</surname><given-names>WS</given-names></name><name><surname>Badner</surname><given-names>NH</given-names></name><name><surname>Choi</surname><given-names>P</given-names></name></person-group><article-title>Epidural analgesia reduces postoperative myocardial infarction: A meta-analysis</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><fpage>853</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11574345</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarthy</surname><given-names>M</given-names></name><name><surname>Nadiminti</surname><given-names>S</given-names></name><name><surname>Krishnamurthy</surname><given-names>J</given-names></name><name><surname>Thimmannagowda</surname><given-names>P</given-names></name><name><surname>Jawali</surname><given-names>V</given-names></name><name><surname>Royse</surname><given-names>CF</given-names></name><etal/></person-group><article-title>Temporary neurologic deficits in patients undergoing cardiac surgery with thoracic epidural supplementation</article-title><source>J Cardiothorac Vasc Anesth</source><year>2004</year><volume>18</volume><fpage>512</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15365938</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horlocker</surname><given-names>TT</given-names></name><name><surname>Wedel</surname><given-names>DJ</given-names></name><name><surname>Rowlingson</surname><given-names>JC</given-names></name><name><surname>Enneking</surname><given-names>FK</given-names></name><name><surname>Kopp</surname><given-names>SL</given-names></name><name><surname>Benzon</surname><given-names>HT</given-names></name><etal/></person-group><article-title>Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)</article-title><source>Reg Anesth Pain Med</source><year>2010</year><volume>35</volume><fpage>64</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">20052816</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogarten</surname><given-names>W</given-names></name><name><surname>Vandermeulen</surname><given-names>E</given-names></name><name><surname>Van Aken</surname><given-names>H</given-names></name><name><surname>Kozek</surname><given-names>S</given-names></name><name><surname>Llau</surname><given-names>JV</given-names></name><name><surname>Samama</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Regional anaesthesia and antithrombotic agents: Recommendations of the European Society of Anaesthesiology</article-title><source>Eur J Anaesthesiol</source><year>2010</year><volume>27</volume><fpage>999</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">20890208</pub-id></element-citation></ref></ref-list></back></article>